Aug 6, 2020 – 4.17pm by Yolanda Redrup In the eight years since former Monash University professor Andreas Fouras founded soon-to-be listed lung imaging medical technology company 4D Medical, he has put everything on the line to get his business to where it is... Read More »

14 Jul 2020 : The Australian Financial Review

Going from uni lab to hospital theatre demands huge sacrifice

Andreas Fouras imagined he would always be a university professor. The research milieu suited him and he made the transition from graduate to professor in biomechanical engineering in a remarkably short six years. Now he has logged seven years running a biomedical company and his... Read More »

14 Jul 2020 : The Sydney Morning Herald

Lung tracker gears up for ASX launch

Home grown lung tracker biotech 4DMedical has confirmed it expects to hit the ASX boards on August 14th after it completes a $50 million IPO with shares on offer at 73c each. The company’s XV Technology platforms helps doctors track respiratory illnesses with more accuracy... Read More »
In a few weeks time respiratory diagnostic company 4DMedical will list on the ASX. The company’s technology, XV, helps physicians monitor lung performance and identify disorders utilising less radiation and no dyes at all. 4DMedical has launched a $50m IPO and is expected to list... Read More »

13 Jul 2020 : The Courier Mail

The City Beat

BREATHING EASIER Brisbane-born entrepreneur Andreas Fouras (illustrated) is poised to radically shake up how doctors around the world diagnose and treat lung ailments. His start-up company 4DMedical announced a $50m IPO on Friday to drive the growth of groundbreaking technology he developed and which he... Read More »